CORONAVIRUS/Medigen to partner with U.S. company on COVID-19 vaccine patch

11/01/2021 10:02 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, Nov. 1 (CNA) Medigen Vaccine Biologics Corp. is partnering with an American biotech company to develop a COVID-19 vaccine patch, which could begin human clinical trials as early as in 2022, the Taiwanese vaccine maker announced Monday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

View All
We value your privacy.
Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.